(MLM) Martin Marietta Materials - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5732841060
Stock: Aggregates, Cement, Concrete, Asphalt, Lime
Total Rating 56
Risk 82
Buy Signal 0.24
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.58% |
| Yield on Cost 5y | 1.11% |
| Yield CAGR 5y | 8.25% |
| Payout Consistency | 99.1% |
| Payout Ratio | 22.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.9% |
| Relative Tail Risk | -0.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 16.68 |
| Character TTM | |
|---|---|
| Beta | 0.671 |
| Beta Downside | 0.375 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.77% |
| CAGR/Max DD | 0.98 |
Description: MLM Martin Marietta Materials January 29, 2026
Martin Marietta Materials (NYSE: MLM) is a natural-resource-based building-materials producer that supplies aggregates, ready-mix concrete, asphalt, cement, and magnesia-based chemicals to U.S. and international construction, rail, agricultural, utility, and environmental markets.
In its most recent quarter (Q2 2024), the company reported revenue of $1.62 billion, a 5 % year-over-year increase, and adjusted earnings per share of $1.12, with an operating margin of roughly 12 %. The cement segment contributed about 22 % of total sales, reflecting continued demand from infrastructure projects.
Key macro drivers include the U.S. construction-spending outlook, which the U.S. Census Bureau projects to grow at an average 3 % annual rate through 2027, and the lingering impact of the 2021 Infrastructure Investment and Jobs Act, which is expected to sustain elevated demand for aggregates and cement. Conversely, the sector remains sensitive to interest-rate cycles and potential slowdowns in residential construction.
For a data-rich, unbiased deep-dive into MLM’s valuation metrics and scenario analysis, you may find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.24 > 1.0 |
| NWC/Revenue: 34.17% < 20% (prev 20.36%; Δ 13.80% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.84b > Net Income 1.15b |
| Net Debt (5.85b) to EBITDA (2.21b): 2.64 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.4m) vs 12m ago -1.47% < -2% |
| Gross Margin: 29.81% > 18% (prev 0.29%; Δ 2953 % > 0.5%) |
| Asset Turnover: 37.82% > 50% (prev 39.54%; Δ -1.73% > 0%) |
| Interest Coverage Ratio: 7.14 > 6 (EBITDA TTM 2.21b / Interest Expense TTM 222.0m) |
Altman Z'' 3.21
| A: 0.12 (Total Current Assets 3.42b - Total Current Liabilities 1.15b) / Total Assets 18.65b |
| B: 0.33 (Retained Earnings 6.17b / Total Assets 18.65b) |
| C: 0.09 (EBIT TTM 1.58b / Avg Total Assets 17.56b) |
| D: 0.69 (Book Value of Equity 6.17b / Total Liabilities 8.91b) |
| Altman-Z'' Score: 3.21 = A |
Beneish M -3.14
| DSRI: 1.05 (Receivables 984.0m/916.0m, Revenue 6.64b/6.51b) |
| GMI: 0.96 (GM 29.81% / 28.74%) |
| AQI: 0.84 (AQ_t 0.26 / AQ_t-1 0.31) |
| SGI: 1.02 (Revenue 6.64b / 6.51b) |
| TATA: -0.04 (NI 1.15b - CFO 1.84b) / TA 18.65b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of MLM shares?
As of February 09, 2026, the stock is trading at USD 690.00 with a total of 481,055 shares traded.
Over the past week, the price has changed by +5.45%, over one month by +8.13%, over three months by +12.02% and over the past year by +30.70%.
Over the past week, the price has changed by +5.45%, over one month by +8.13%, over three months by +12.02% and over the past year by +30.70%.
Is MLM a buy, sell or hold?
Martin Marietta Materials has received a consensus analysts rating of 4.04.
Therefore, it is recommended to buy MLM.
- StrongBuy: 11
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MLM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 685.5 | -0.7% |
| Analysts Target Price | 685.5 | -0.7% |
| ValueRay Target Price | 856.2 | 24.1% |
MLM Fundamental Data Overview February 07, 2026
P/E Trailing = 34.4828
P/E Forward = 30.581
P/S = 6.0281
P/B = 4.1565
P/EG = 3.584
Revenue TTM = 6.64b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 2.21b USD
Long Term Debt = 5.29b USD (from longTermDebt, last quarter)
Short Term Debt = 291.0m USD (from shortTermDebt, last quarter)
Debt = 5.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.85b USD (from netDebt column, last quarter)
Enterprise Value = 47.46b USD (41.61b + Debt 5.90b - CCE 57.0m)
Interest Coverage Ratio = 7.14 (Ebit TTM 1.58b / Interest Expense TTM 222.0m)
EV/FCF = 47.13x (Enterprise Value 47.46b / FCF TTM 1.01b)
FCF Yield = 2.12% (FCF TTM 1.01b / Enterprise Value 47.46b)
FCF Margin = 15.16% (FCF TTM 1.01b / Revenue TTM 6.64b)
Net Margin = 17.35% (Net Income TTM 1.15b / Revenue TTM 6.64b)
Gross Margin = 29.81% ((Revenue TTM 6.64b - Cost of Revenue TTM 4.66b) / Revenue TTM)
Gross Margin QoQ = 33.10% (prev 30.04%)
Tobins Q-Ratio = 2.54 (Enterprise Value 47.46b / Total Assets 18.65b)
Interest Expense / Debt = 1.00% (Interest Expense 59.0m / Debt 5.90b)
Taxrate = 19.78% (89.0m / 450.0m)
NOPAT = 1.27b (EBIT 1.58b * (1 - 19.78%))
Current Ratio = 2.97 (Total Current Assets 3.42b / Total Current Liabilities 1.15b)
Debt / Equity = 0.61 (Debt 5.90b / totalStockholderEquity, last quarter 9.73b)
Debt / EBITDA = 2.64 (Net Debt 5.85b / EBITDA 2.21b)
Debt / FCF = 5.81 (Net Debt 5.85b / FCF TTM 1.01b)
Total Stockholder Equity = 9.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.56% (Net Income 1.15b / Total Assets 18.65b)
RoE = 12.24% (Net Income TTM 1.15b / Total Stockholder Equity 9.41b)
RoCE = 10.78% (EBIT 1.58b / Capital Employed (Equity 9.41b + L.T.Debt 5.29b))
RoIC = 8.56% (NOPAT 1.27b / Invested Capital 14.85b)
WACC = 7.45% (E(41.61b)/V(47.51b) * Re(8.39%) + D(5.90b)/V(47.51b) * Rd(1.00%) * (1-Tc(0.20)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.30%
[DCF Debug] Terminal Value 79.89% ; FCFF base≈812.5m ; Y1≈795.9m ; Y5≈808.8m
Fair Price DCF = 168.3 (EV 16.00b - Net Debt 5.85b = Equity 10.15b / Shares 60.3m; r=7.45% [WACC]; 5y FCF grow -2.99% → 2.90% )
EPS Correlation: 2.22 | EPS CAGR: -15.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: 31.08 | Revenue CAGR: 5.76% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.65 | Chg30d=+0.058 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=21.97 | Chg30d=-0.232 | Revisions Net=-2 | Growth EPS=+19.8% | Growth Revenue=+9.5%
P/E Forward = 30.581
P/S = 6.0281
P/B = 4.1565
P/EG = 3.584
Revenue TTM = 6.64b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 2.21b USD
Long Term Debt = 5.29b USD (from longTermDebt, last quarter)
Short Term Debt = 291.0m USD (from shortTermDebt, last quarter)
Debt = 5.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.85b USD (from netDebt column, last quarter)
Enterprise Value = 47.46b USD (41.61b + Debt 5.90b - CCE 57.0m)
Interest Coverage Ratio = 7.14 (Ebit TTM 1.58b / Interest Expense TTM 222.0m)
EV/FCF = 47.13x (Enterprise Value 47.46b / FCF TTM 1.01b)
FCF Yield = 2.12% (FCF TTM 1.01b / Enterprise Value 47.46b)
FCF Margin = 15.16% (FCF TTM 1.01b / Revenue TTM 6.64b)
Net Margin = 17.35% (Net Income TTM 1.15b / Revenue TTM 6.64b)
Gross Margin = 29.81% ((Revenue TTM 6.64b - Cost of Revenue TTM 4.66b) / Revenue TTM)
Gross Margin QoQ = 33.10% (prev 30.04%)
Tobins Q-Ratio = 2.54 (Enterprise Value 47.46b / Total Assets 18.65b)
Interest Expense / Debt = 1.00% (Interest Expense 59.0m / Debt 5.90b)
Taxrate = 19.78% (89.0m / 450.0m)
NOPAT = 1.27b (EBIT 1.58b * (1 - 19.78%))
Current Ratio = 2.97 (Total Current Assets 3.42b / Total Current Liabilities 1.15b)
Debt / Equity = 0.61 (Debt 5.90b / totalStockholderEquity, last quarter 9.73b)
Debt / EBITDA = 2.64 (Net Debt 5.85b / EBITDA 2.21b)
Debt / FCF = 5.81 (Net Debt 5.85b / FCF TTM 1.01b)
Total Stockholder Equity = 9.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.56% (Net Income 1.15b / Total Assets 18.65b)
RoE = 12.24% (Net Income TTM 1.15b / Total Stockholder Equity 9.41b)
RoCE = 10.78% (EBIT 1.58b / Capital Employed (Equity 9.41b + L.T.Debt 5.29b))
RoIC = 8.56% (NOPAT 1.27b / Invested Capital 14.85b)
WACC = 7.45% (E(41.61b)/V(47.51b) * Re(8.39%) + D(5.90b)/V(47.51b) * Rd(1.00%) * (1-Tc(0.20)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.30%
[DCF Debug] Terminal Value 79.89% ; FCFF base≈812.5m ; Y1≈795.9m ; Y5≈808.8m
Fair Price DCF = 168.3 (EV 16.00b - Net Debt 5.85b = Equity 10.15b / Shares 60.3m; r=7.45% [WACC]; 5y FCF grow -2.99% → 2.90% )
EPS Correlation: 2.22 | EPS CAGR: -15.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: 31.08 | Revenue CAGR: 5.76% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.65 | Chg30d=+0.058 | Revisions Net=-1 | Analysts=9
EPS next Year (2026-12-31): EPS=21.97 | Chg30d=-0.232 | Revisions Net=-2 | Growth EPS=+19.8% | Growth Revenue=+9.5%